Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 409
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05118724 | Atezolizumab in Patients With MSI-h/MMR-D Stage II High Risk and Stage III Colorectal Cancer Ineligible for Oxaliplatin | ||
| NCT01558167 | A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia | ||
| NCT00205556 | Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients | ||
| NCT01259856 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | ||
| NCT05300282 | Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients | ||
| NCT01697267 | Rituximab Vasculitis Maintenance Study | ||
| NCT02925234 | The Drug Rediscovery Protocol (DRUP Trial) | ||
| NCT01723111 | Impact of Dialysis Modality on Hepcidin and Iron Metabolism | ||
| NCT02758665 | Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL | ||
| NCT03224208 | Vemurafenib Plus Cobimetinib in Advanced or Metastatic Melanoma Patients | ||
| NCT02383290 | The Implementation of Pharmacogenomics Into Primary Care in British Columbia | ||
| NCT01709097 | Compliance/Adherence After Kidney Transplant, With or With Out Med-O-Wheel™. | ||
| NCT01185223 | Study Comparing Valganciclovir Versus Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation | ||
| NCT02344472 | Detect V / CHEVENDO (Chemo vs. Endo) | ||
| NCT01596790 | COLOSPOT Study : Assessment by EPISPOT of Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer | ||
| NCT01565200 | HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1 | ||
| NCT00944684 | High Dose Ribavirin in the Treatment of Chronic Hepatitis C | ||
| NCT00509184 | Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma | ||
| NCT00285233 | Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes | ||
| NCT00275535 | The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients | ||
| NCT03915678 | Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors | ||
| NCT03946358 | Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) | ||
| NCT00411762 | A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma | ||
| NCT01368848 | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | ||
| NCT01329952 | Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment | ||
| NCT00694408 | A Pilot Trial of Pediatric Liver Transplantation Without Steroids | ||
| NCT00901524 | ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV | ||
| NCT03831490 | Study for Improving Maternal, Pregnancy and Child Outcomes | ||
| NCT04888221 | Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement | ||
| NCT03449914 | The GOLD Study: G8 in OLDer Patients | ||
| NCT00438152 | Lopinavir Capsules to Kaletra or Invirase Tablets | ||
| NCT01471470 | Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer | ||
| NCT05050214 | Obinutuzumab in Primary MN | ||
| NCT03498625 | Crohn's Disease Endoscopic REmission Definition in an Objective Way | ||
| NCT03892525 | Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma | ||
| NCT04470947 | Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies | ||
| NCT04245085 | ABC-lung: Atezolizumab, Bevacizumab and Chemotherapy in EGFR-mutant Non-small Cell Lung Carcinoma | ||
| NCT01066689 | Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation | ||
| NCT00769522 | FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia | ||
| NCT01683175 | Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation | ||
| NCT03134794 | Medical Education for Better Multiple Sclerosis Outcomes | ||
| NCT01205854 | Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial | ||
| NCT00405860 | CellCept in p-ANCA Vasculitis | ||
| NCT00957866 | Prospective Anti-Hepatitis C Virus (Anti-HCV) Trial of Peg-Interferon and Ribavirin in Subjects of First Nations, Metis and Caucasian Ethnicity | ||
| NCT02433522 | Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab | ||
| NCT04770272 | Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy | ||
| NCT02213653 | Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency | ||
| NCT03691077 | Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714 | ||
| NCT01332929 | Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain Metastasis | ||
| NCT00620269 | Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III |
